Nasdaq
NRSN
NeuroSense Therapeutics Ltd.
- Health Care
- Israel
- Listed 2021
- 1 day
- −7.2%
- 1 month
- −29.0%
- 1 year
- −62.5%
$0.5030 · Mkt cap $19.0M
At the 6 Aug 2026 close
Nasdaq
NeuroSense Therapeutics Ltd.
$0.5030 · Mkt cap $19.0M
At the 6 Aug 2026 close
NeuroSense Therapeutics Ltd. trades under the ticker NRSN on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2021. Its market capitalisation is $19.0M. The last closing price was $0.5030, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −62.5%, and −29.0% over the past month. Returns are price returns and exclude dividends.
This page exists because NRSN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.